324 Kova´cs et al.
of 2. The mixture was stirred at 110◦C for a day,
and for other 2 days at rt. After filtration, the fil-
trate was evaporated. The purification of the crude
product by column chromatography (silica gel, 2%
methanol in chloroform) led to 1.5 g of light yel-
low oil, containing dimers 5 (94%) and 5ꢁ (6%). The
fraction was further purified by column chromatog-
raphy to furnish 1.3 g (62%) of dimer 5. 31P NMR
(CDCl3) δ 57.0 (P(1)), 83.1 (P(8)), J = 35.1; 13C NMR
(CDCl3) δ 11.7 (C(2) Me),a 12.8 (J = 11.6, C(4)–
Me),a 41.2 (Jꢁ = 76.3, Jꢁꢁ = 11.5, C(7a)), 41.6 (Jꢁꢁ =
60.2, C(7)), 51.3 (Jꢁꢁ = 70.0, C(4)), 53.3 (Jꢁ = 13.3,
Jꢁꢁ = 13.4, C(3a)), 126.3 (J = 85.6, C(1ꢁ)),b 128.1 (J =
10.8, C(3ꢁ)),c 128.4 (J = 11.8, C(3ꢁꢁ)),c 130.2 (J = 10.3,
C(2ꢁ)),c 131.7 (C(4ꢁ), C(4ꢁꢁ)), 131.9 (J = 95.3, C(1ꢁꢁ)),b
130.0 (J = 8.5, C(6)), 132.8 (J = 7.7, C(2ꢁꢁ)),c 132.9
(Jꢁꢁ = 7.2, C(5)), 139.8 (Jꢁ = 90.3, C(2)), 140.8 (Jꢁ =
30.3, Jꢁꢁ = 8.6, C(3)); a−cmay be reversed; Jꢁ: cou-
0.12 mol) [16]. After 4 h of reflux, the mixture was
stirred at rt overnight. The mixture was treated with
concentrated hydrochloric acid (10 mL) in water
(100 mL). The extraction with chloroform led to
15.2 g (64%) of 1H-phosphole oxide 7. The crude
product was purified by fractional distillation to give
5.9 g (25%) of 7. bp 115–117◦C (0.12 Hg mm); mp
63–64◦C (10% chloroform in toluene), colorless, hy-
groscopic crystals.
7: 31P NMR (CDCl3) δ 73.1; 13C NMR (CDCl3) δ
20.2 (J = 10.1, C(3) Me), 25.2 (J = 2.8, C(2ꢁ) and
C(6ꢁ)), 25.9 (J = 1.2, C(4ꢁ)), 26.2 (J = 13.1, C(3ꢁ) and
C(5ꢁ)), 30.2 (J = 61.3, C(5)),a 33.4 (J = 64.1, C(2)),a
38.5 (J = 64.5, C(1ꢁ)), 120.9 (J = 6.9, C(4)), 136.9
(J = 11.7, C(3)); amay be reversed; 1H NMR (CDCl3)
δ 1.67 (s, 3H, Me), 5.38–5.55 (m, 1H, C(4) H);
HR-MS (M + H)+found = 199.1237, C11H20PO requires
199.1252.
1
pled by P(1), Jꢁꢁ: coupled by P(8); H NMR (CDCl3)
δ 1.65 (d, JPH = 16.0, 3H, Me), 1.82 (d, JPH = 11.5,
3H, Me), 3.46 (d, 1H, JHH = 8, C(7a) H), 3.61 (s,
1H, C(7) H), 3.95 (m, 1H, C(3a) H), 5.79 (dd, 1H,
3,4-Dibromo-1-cyclohexyl-3-methyl-2,3,4,5-
tetrahydro-1H-phosphole 1-Oxide (8)
JHH = 7.0, JPH = 11.0, C(5) H), 6.47 (d, 1H, JPH
=
0.5 mL (9.8 mmol) of bromine in 5 mL of chloro-
form was added to the 35 mL of chloroform solution
of 1.6 g (8.1 mmol) of 7 at 0◦C. After 0.5 h of stir-
ring, the mixture was allowed to warm up to room
temperature and the stirring was continued for 4 h.
Volatile components were then removed. Purifica-
tion of the crude product by column chromatogra-
phy (silica gel, 3% methanol in chloroform) afforded
2.8 g (93%) of 8 as the mixture of two isomers (A and
B). HR-MS (M + H)+found = 356.9607, C11H20PO79Br2
requires 356.9616.
41.0, C(3) H), 6.62 (m, 1+H, C(6) H), 7.40–7.72 (10H,
Ar H); HR-MS: (M + H)found = 381.1115, C22H23P2O2
requires 381.1173.
The other fraction (0.20 g) consisted of 76% 5
and 24% 5ꢁ.
5ꢁ: 31P NMR (CDCl3) δ 56.1 (P1), 81.8 (P8), J =
35.8; 13C NMR (CDCl3) δ 12.3 (J = 11.7, C(4) Me),a
12.6 (C(2) Me),a 44.6 (Jꢁꢁ = 65.9, C(7)), 46.1 (Jꢁ =
75.9, Jꢁꢁ = 12.7, C(7a)), 48.7 (Jꢁ = 13.0, Jꢁꢁ = 13.0,
C(3a)), 50.9 (Jꢁ = 2.5, Jꢁꢁ = 65.6, C(4)), 125.8 (J =
10.4, C(6)), 128.4 (J = 10.8, C(3ꢁ)),b 128.7 (J =
11.6, C(2ꢁ)),b 128.8 (J = 11.8, C(3ꢁꢁ)),b 130.3 (J =
8.9, C(2ꢁꢁ)),b C(1ꢁ) overlapped at around 131,c 132.0
(C(4ꢁ), C(4ꢁꢁ)), 133.2 (J = 95.1, C(1ꢁꢁ)),c 137.5 (Jꢁ =
5.3, Jꢁꢁ = 13.3, C(5)), 139.3 (Jꢁ = 90.1, Jꢁꢁ = 4.2, C(2)),
143.0 (Jꢁ = 30.2, Jꢁꢁ = 10.5, C(3)); a−cmay be reversed;
8A: 31P NMR (CDCl3) δ 61.8; 13C NMR (CDCl3)
δ 24.1 (J = 7.9, C(2ꢁ)), 25.0 (C(4ꢁ)), 25.4 (J = 13.6,
C(3ꢁ)), 30.8 (J = 5.7, C(3) Me), 35.4 (J = 55.8, C(5)),
39.7 (J = 67.5, C(1ꢁ)), 40.8 (J = 56.2, C(2)), 57.2 (J =
1
5.6, C(4)), 66.8 (J = 6.7, C(3)); H NMR (CDCl3) δ
2.15 (s, 3H, Me), 2.42–2.51 (m), 2.59–2.71 (m), 2.88–
2.95 (m), 4H, 2CH2, 4.60–4.68 (m, 1H, C(4) H).
8B: 31P NMR (CDCl3) δ 66.0; 13C NMR (CDCl3)
δ 24.2 (J = 11.7, C(2ꢁ)), 25.0 (C(4ꢁ)), 25.3 (J = 13.6,
C(3ꢁ)), 32.4 (J = 9.4, C(3) Me), 36.5 (J = 57.2, C(5)),
39.7 (J = 60.7, C(2)), 41.3 (J = 68.1, C(1ꢁ)), 50.9 (J =
4.4, C(4)), 67.1 (J = 4.8, C(3)).
1
Jꢁ: coupled by P(1), Jꢁꢁ: coupled by P(8); H NMR
(CDCl3) δ 1.71 (d, JPH = 16.0, 3H, Me), 1.80 (d, JPH
=
9.0, 3H, Me), 3.21 (d, 1H, JHH = 8.0, CH, C(7a) H),
3.43 (s, 1H, CH, C(7) H), 4.28 (m, 1H, C(3a) H), 6.07
(m, 1H, C(6) H), 6.39 (d, 1H, JPH = 42.5, C(3) H),
6.48 (dd, 1H, JHH = 7.5, JPH = 12.5, C(5) H), 7.35–
7.73 (10H, Ar H).
3,10-Dicyclohexyl-5,8-dimethyl-3,10-diphos-
phatricyclo[5.2.1.02,6]deca-4,8-diene-3,10-
dioxide (11) [15]
Synthesis of 3-Methyl-1-cyclohexyl-2,5-dihydro-
1H-phosphole Oxide (7)
The Grignard reagent prepared from magnesium
(8.4 g, 0.36 mol) and cyclohexylbromide (24.5 g,
0.15 mol) in THF (100 mL) was added dropwise with
cooling to the THF solution (100 mL) of 1-chloro-
2,5-dihydro-3-methyl-1H-phosphole 1-oxide (18.6 g,
1.4 mL (10.1 mmol) of triethylamine was added to
the 25 mL of toluene solution of 1.51 g (4.24 mmol)
of 8. The mixture was stirred at 110◦C for 3 days.
After filtration, the filtrate was evaporated and the